312) van den Broek MD, Lightbody CE. The 12-month effects of early motivational interviewing after acute stroke: a randomized controlled trial. *Stroke*. 2011;42:1956-1961
313) Mitchell PH, Veith RC, Becker KJ, Buzaitis A, Cain KC, Fruin M, Tirschwell D, Teri L. Brief psychosocial-behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant: living well with stroke: randomized, controlled trial. *Stroke*. 2009;40:3073-3078
314) Hackett ML, Yang M, Anderson CS, Horrocks JA, House A. Pharmaceutical interventions for emotionalism after stroke. *Cochrane Database Syst Rev*. 2010;CD003690
315) Legg LA, Quinn TJ, Mahmood F, Weir CJ, Tierney J, Stott DJ, Smith LN, Langhorne P. Non-pharmacological interventions for caregivers of stroke survivors. *Cochrane Database Syst Rev*. 2011:CD008179
316) Hackett ML, Anderson CS, House AO. Management of depression after stroke: a systematic review of pharmacological therapies. *Stroke*. 2005;36:1098-1103
317) Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. *Cochrane Database Syst Rev*. 2008:CD003689
318) Chen Y, Patel NC, Guo JJ, Zhan S. Antidepressant prophylaxis for poststroke depression: a meta-analysis. *Int Clin Psychopharmacol*. 2007;22:159-166
319) Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, Fonzetti P, Hegel M, Arndt S. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. *JAMA*. 2008;299:2391-2400
320) Yi ZM, Liu F, Zhai SD. Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta-analysis. *Int J Clin Pract*. 2010;64:1310-1317
321) Tsai CS, Wu CL, Chou SY, Tsang HY, Hung TH, Su JA. Prevention of poststroke depression with milnacipran in patients with acute ischemic stroke: a double-blind randomized placebo-controlled trial. *Int Clin Psychopharmacol*. 2011;26:263-267
322) Salter KL, Foley NC, Zhu L, Jutai JW, Teasell RW. Prevention of Poststroke Depression: Does Prophylactic Pharmacotherapy Work? *J Stroke Cerebrovasc Dis*. 2012
323) Ramasubbu R. Therapy for prevention of post-stroke depression. *Expert Opin Pharmacother*. 2011;12:2177-2187
324) Klehmet J, Harms H, Richter M, Prass K, Volk H, Dirnagl U, Meisel A, Meisel C. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. *Neuroscience*. 2009;158:1184-1193
325) Westendorp WF, Nederkoorn PJ, Vermeij JD, Dijkgraaf MG, van de Beek D. Post-stroke infection: A systematic review and meta-analysis. *BMC Neurol*. 2011;11:110
326) Caldeira D, Alarc√£o J, Vaz-Carneiro A, Costa J. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis. *BMJ: British Medical Journal*. 2012;345
327) Nakashima T, Hattori N, Okimoto M, Yanagida J, Kohno N. Nicergoline Improves

<PAGE>119